Soleus Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-244,627	Closed	-$5.1M	–	74
2023 Q3	$5.1M	Buy	244,627 +178,627	+271%	+$3.72M	0.47%	53
2023 Q2	$1.58M	Sell	66,000 -124,000	-65%	-$2.97M	0.18%	77
2023 Q1	$3.58M	Buy	+190,000	New	+$3.58M	0.37%	57